Related Experiment Videos
Propranolol corrects the abnormal catecholamine response to light during migraine.
1Institute of Neurology and Psychiatry, Bucharest, Rumania.
European Neurology
|January 1, 1990
Summary
Propranolol therapy normalized abnormal catecholamine (CA) responses to light in migraine patients. This suggests propranolol
Area of Science:
- Neuroscience
- Pharmacology
- Migraine Research
Background:
- Migraine is often associated with abnormal physiological responses.
- Catecholamine (CA) release patterns may play a role in migraine pathogenesis.
Purpose of the Study:
- To investigate the effect of propranolol on catecholamine (CA) excretion in response to light in migraine patients.
- To explore the potential mechanism of propranolol's therapeutic effect in migraine.
Main Methods:
- Studied 25 migraine patients before and after 10 days of propranolol therapy (60 mg daily).
- Measured catecholamine (epinephrine and norepinephrine) excretion in response to light exposure.
Main Results:
- Before propranolol, light exposure caused increased epinephrine and decreased norepinephrine excretion.
- After propranolol treatment, this abnormal CA response to light was no longer observed.
Conclusions:
- Propranolol normalizes the abnormal catecholamine response to light in migraineurs.
- Preventing light-induced epinephrine release may be how propranolol exerts its beneficial effect in migraine treatment.